SphynKx Therapeutics' Grant - III Round

SphynKx Therapeutics raised a round of funding on September 23, 2013. Investors include National Institutes of Health.

SphynKx Therapeutics is a privately held biotechnology company based in Charlottesville, VA. We are focused on discovering, developing, and commercializing novel sphingosine kinase (SphK) inhibitors f…

Articles about SphynKx Therapeutics' Grant - III Round: